Sector: Health Care
Director information for LIVANOVA PLC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Brooke Story | Separation and Integration Lead | 54 | ["Senior executive with expertise in international business strategy and operations in the highly regulated medical technology industry","Led complex, high-value mergers and acquisitions","Strong track record of strategic execution and value creation","Experience in mentoring and developing talent"] | ["Nominating and Corporate Governance"] | 2026 |
| Donald Zurbay | Director | 58 | ["More than 30 years of experience in finance and accounting","20 years spent in leadership positions within the global healthcare industry","Former President and Chief Executive Officer of Patterson Companies, Inc.","Former Chief Financial Officer (CFO) of Patterson","Various leadership roles for St. Jude Medical","Tenures at PricewaterhouseCoopers, The Valspar Corporation, and Deloitte & Touche","Bachelor’s degree in Business Accounting from the University of Minnesota","Extensive executive leadership experience in the healthcare industry","Strong background in finance, accounting, and strategic transactions","Expertise in global operations and strategy, investor relations, and advancing science, technology, and innovation","Public board experience","Audit committee financial expert"] | ["Audit and Compliance"] | 2026 |
| Francesco Bianchi | Chair of Seven Capital Partners S.r.l. | 69 | ["over 30 years of mergers and acquisitions experience","strategic advisory experience","former CEO of Seven Capital Partners","general manager at JPMorgan Chase","head of mergers and acquisitions and corporate finance division at Bankers Trust","headed strategic planning division of Banca-Intesa S.p.A.","degree in Economic Sciences with honors","Chartered Accountant","audit committee financial expert"] | ["Audit and Compliance","Compensation and Human Capital Management"] | 2026 |
| J. Christopher Barry | Director | 54 | ["Former Executive Vice President and Group President at Solventum","Former CEO and board member of NuVasive, Inc.","Former Senior Vice President and President of Surgical Innovations at Medtronic","Experience in medical device technologies, international business strategy, and mergers and acquisitions","Expertise in corporate governance matters","Audit committee financial expert"] | ["Audit and Compliance","Nominating and Corporate Governance"] | 2026 |
| Jette Nygaard-Andersen | Chair of the Board | 57 | ["Chair of the Board of a global medical technology company","Chief Executive Officer and Executive Director of Entain Group PLC","Non-Executive Director of Entain","Chief Operating Officer and Chief Executive Officer of multiple business units at Modern Times Group AB","Senior Managing Director at Accenture","Master of Science degree in Business Administration with a concentration in Finance"] | ["Remuneration and Nomination Committee","Audit Committee"] | 2026 |
| Peter Wilver | Director | 66 | ["Former Chief Financial Officer of a publicly traded multinational company","Significant public company experience in financial reporting","Investor relations","Strategic planning","Business development","Compensation planning","Strategy formation and execution","Audit committee financial expert"] | ["Audit and Compliance","Compensation and Human Capital Management"] | 2026 |
| Stacy Enxing Seng | Operating Partner | 61 | ["Operating Partner with Lightstone Ventures","Former President, Vascular Therapies at Covidien","Former President, Peripheral Vascular at Covidien","Executive officer and founding member of ev3","Experience in strategy, marketing, sales, innovation, and mergers and acquisitions in the medical device industry","Experience with human capital management matters and compensation analysis"] | ["Compensation and Human Capital Management"] | 2026 |
| Susan Podlogar | Independent | 62 | ["Executive Vice President, Chief Human Resources Officer at MetLife","Leadership roles at Johnson & Johnson","Positions with Bayer Pharmaceutical, Bristol-Myers Squibb, and William M. Mercer","MBA from the University of South Florida","Bachelor’s degree in Labor and Industrial Relations and Business Administration from the University of Wisconsin-Parkside"] | ["Compensation and Human Capital Management"] | 2026 |
| Todd Schermerhorn | Director | 65 | ["Senior Vice President and Chief Financial Officer of C. R. Bard, Inc.","Vice President and Treasurer of C. R. Bard","Experience in public company and financial reporting","Investor and public relations experience","Audit committee financial expert"] | ["Audit and Compliance"] | 2026 |
| Vladimir A. Makatsaria | Chief Executive Officer | 53 | ["Chief Executive Officer at LivaNova","27 years at Johnson & Johnson in executive leadership roles","Company Group Chairman at J&J MedTech","Led J&J China, J&J MedTech APAC, and Ethicon EMEA","Chairman of the Board of the Asia Pacific Medical Technology Association","Advisory Board Member to Singapore Management University","Three degrees from the University of Minnesota: bachelor's in Physiology, MBA, master's in Healthcare Administration"] | [] | 2026 |
| William A. Kozy | Chair | 74 | ["Chair of LivaNova","Interim Chief Executive Officer of LivaNova from April 2023 to February 2024","Retired from Becton, Dickinson and Company in 2016","Executive Vice President and Chief Operating Officer at Becton Dickinson from 2011 to 2016","Experience with global medical device companies","Expertise in executive leadership, innovation, operations, manufacturing, and enterprise resource planning implementation","Experience in global strategy, mergers and acquisitions, technology, and product development","Experience in investor engagement and corporate governance matters such as succession planning"] | [] | 2026 |
